Health Condition 1: K869- Disease of pancreas, unspecified
Conditions
Interventions
Intervention1: Not applicable: Not applicable
Control Intervention1: Not applicable: Not applicable
Sponsors
UNIVERSITY OF ZURICH
Eligibility
Inclusion criteria
Inclusion criteria: Consecutive adult patients more than 18 years of age of both sexes who underwent robotic pancreatoduodenectomy for malignant or benign disease. Date of surgery between 01.01.2020 to 31.12.2023 4-year study period
Exclusion criteria
Exclusion criteria: Patients who underwent open or laparoscopic pancreatoduodenectomy Date of surgery outside the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the postoperative complications after robotic pancreatoduodenectomy assessed by the Clavien-Dindo Classification and the Comprehensive Complication Index up to 6 months after surgery.Timepoint: Post operative complications will be calculated for 6 months from date of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Pancreas-specific complications and pathological and survival details.Timepoint: Pancreas-specific complications and pathological and survival will be calculated as the time between date of the surgery to the date of the last known follow-up visit or death 5 years | — |
Countries
Brazil, China, France, Hong Kong, India, Italy, Japan, Netherlands, New Zealand, Portugal, Republic of Korea, Singapore, Spain, Switzerland, United States of America
Contacts
Public ContactDr Shailesh Shrikhande
TATA MEMORIAL HOSPITAL
Outcome results
None listed